The global point-of-care ultrasound device market will grow at a CAGR of 6.1% owing to the increased healthcare costs, growing geriatric population, emerging healthcare infrastructure, and rising incidences of chronic diseases will propel the growth of the point-of-care ultrasound device market. Moreover, the robust technological development in healthcare services, rising number of patient admissions in emergency care will lead to the adoption of fast and precise diagnostics technology in the emergency department, thereby the adoption of point-of-care devices to reduce the delay between the beginning of symptoms and taking a decision on a definitive therapy so as to decrease mortality and morbidity in the critically ill patient.

The ongoing COVID-19 outbreak has a significant impact across all industries and the market for point-of-care ultrasound devices has also been affected by it. The production and manufacturing of point-of-care ultrasound devices have had an adverse impact owing to strict lockdown measures that have reduced the labor force, restrictions in producing goods with proper sanitization, growing unemployment rate, and has put restrictions on import and export services.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/point-of-care-ultrasound-device-market/request-sample

Based on type, the diagnostic type dominates the global point-of-care ultrasound device market during the forecast period 2021-2027 owing to the rising adoption of these devices in point-of-care diagnostic applications like a cardiac ultrasound for left ventricular systolic function, pericardial effusion, and severe mitral regurgitation, as well as for pleural effusion, pneumothorax, and pulmonary edema.

Europe is anticipated to have a significant share in the point-of-care ultrasound devices market owing to the increased prominence of chronic diseases, rise in spending on healthcare infrastructure, technological development. The growing geriatric population suffering from chronic diseases will further drive the growth of the point-of-care ultrasound devices market in Europe. According to Un World Population Ageing 2020, about 140.4 million people in Europe were aged 65 years or above in 2019 and the population might reach 199.9 million by 2050.

In Oct 2021 Mindray Bio-Medical Electronics Co. Ltd has launched a novel point-of-care ultrasound system TE7 Max Ultrasound System, and expand its product portfolio. This new touchscreen ultrasound system has a 21.5 inches vertically oriented high-definition LED display and a sealed touch-based interface to aid clinicians. The targeted solutions in different point-of-care scenarios include anesthesia, critical care, and emergency.

The prominent players in the point-of-care ultrasound device market include Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Koninklijke Philips N.V., General Electric Company, Canon Medical Systems Corporation, Samsung Electronics Co. Ltd., Esaote S.p.A, Hitachi Ltd., Analogic Corporation, and Fujifilm Holdings Corporation.

Source: VynZ Research